Triazolopyrimidine Pharmaceutical Synthesis in Continuous Flow
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional batch processes for synthesizing CB2 receptor agonists using azides pose risks due to the accumulation of hazardous hydrazoic acid (HN3), which is volatile, explosive, and toxic, necessitating safer and more controlled synthesis methods.
Innovation Solution
A continuous flow process using a tubular reactor minimizes HN3 accumulation by employing inline quenching and allows for a variety of temperature ranges, reducing the risk of explosions and exposure through the use of solvents like acetonitrile and bases like DBU, while telescoping multiple reaction steps without intermediate isolation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If batch processes are used for synthesizing CB2 receptor agonists using azides, then the synthesis can be performed with simple equipment and operation, but hazardous hydrazoic acid accumulates creating explosion and exposure risks
Solution Approach 1:
The patent employs continuous flow processing where reactants are continuously fed through a tubular reactor and products are continuously removed, preventing accumulation of hazardous HN3 throughout the process. This continuous operation eliminates the batch-wise accumulation problem while maintaining synthesis efficiency.
Solution Approach 2:
The patent extracts the hazardous HN3 from the reaction system by using inline quenching zones where base solutions neutralize and remove HN3 as it forms. This separation of the hazardous component from the main reaction stream prevents accumulation and exposure risks.
2Productivity
If azide reagents are used under acidic conditions to synthesize triazoles, then the reaction proceeds efficiently, but volatile and explosive hydrazoic acid is generated as a side product
Solution Approach 1:
The patent introduces base solutions as intermediary substances in quenching zones that neutralize HN3 immediately after formation. These base intermediaries convert the hazardous HN3 into non-volatile, non-explosive salts, eliminating the harmful effects while preserving the beneficial reaction efficiency.
Solution Approach 2:
The patent converts the harmful HN3 byproduct into a beneficial neutralization process where the hazardous volatile acid is transformed into safe, non-volatile salt products through inline base treatment. This converts a safety hazard into a controlled chemical transformation.
3Ease of operation
If batch processes are used with azides, then the equipment and operation are simple, but the temperature range must be restricted to prevent explosion
Solution Approach 1:
The continuous flow system maintains simple operation through automated continuous feeding and processing, while simultaneously enabling broader temperature ranges because the continuous removal of HN3 eliminates explosion risks associated with high-temperature batch processing.
Solution Approach 2:
The patent changes the operational parameters from restricted batch temperature ranges to broader continuous flow temperature ranges, enabled by the continuous quenching mechanism that prevents HN3 accumulation even at elevated temperatures.
4Manufacturing precision
If multiple reaction steps are performed in batch processes with intermediate isolation, then each step can be optimized independently, but the process time and complexity increase
Solution Approach 1:
The patent merges multiple reaction steps into a single continuous flow process where sequential reactions occur in different zones of the tubular reactor without intermediate isolation. This combining of steps reduces overall process time while maintaining optimization through controlled residence times and temperatures for each reaction zone.
Solution Approach 2:
The continuous flow process eliminates idle time between batch steps by maintaining uninterrupted reaction flow through the system. Reactants continuously progress through sequential reaction zones, eliminating the time losses associated with batch-wise isolation, drying, and re-dissolution operations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The continuous flow process effectively synthesizes 1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol, minimizing HN3 risks and enabling safer, more efficient production of valuable pharmaceutical compounds.
Implementation Method 1
For continuous flow processes, HN3 accumulation is minimized in the reactor (e.g., tubular reactor) due to the lack of headspace
Implementation Method 2
the process allows for inline quenching of excess azide residues and other hazardous azide waste products
Data Source
AI summary
The present invention relates to a process for the preparation of (3S)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]-6,7-dihydrotriazolo[4,5-d]pyrimidin-7-yl] pyrrolidin-3-ol useful as pharmaceutically active compounds.